Collaborative Study Identifies Fetal Brain Development Programs as the Primary Fuel for Pediatric Ependymoma Growth

Researchers discover that ZFTA-RELA fusion proteins hijack open DNA during fetal development to drive aggressive pediatric ependymoma brain tumors.

By: AXL Media

Published: Mar 26, 2026, 8:53 AM EDT

Source: Information for this report was sourced from Baylor College of Medicine

The Developmental Origins of Pediatric Brain Cancer

Shutterstock

Pediatric brain tumors have long been suspected of originating during the earliest stages of neurological growth, yet the precise moment of transformation from healthy cell to malignancy has remained elusive. Researchers from Baylor College of Medicine and St. Jude Children’s Research Hospital have now identified a specific "window of vulnerability" within the brain's developmental plan. During fetal and early postnatal life, stem-like cells divide at high speeds to produce neurons and glial cells. It is during this phase of rapid division that the DNA structure is naturally accessible, providing an unintended opportunity for cancer-promoting proteins to alter genetic expression.

Unmasking the ZFTA-RELA Fusion Protein Mechanism

The study focused on ZFTA-RELA (ZR) fusion-positive ependymoma, a common and chemo-resistant tumor found almost exclusively in the cerebral cortex of young children. For years, scientists were puzzled by why this specific genetic fusion only resulted in tumors during early childhood. The new findings clarify that the ZR fusion protein does not actually "force" the DNA open. Instead, it acts as an opportunist, taking advantage of the pre-existing open chromatin states that are a natural feature of early brain development. By interacting with this exposed genetic material, the ZR protein reroutes the cell's instructions to drive tumor generation rather than healthy tissue growth.

The Creation of Heterogeneous Tumor Clones